Lonza and Patheon Extend Exclusivity and Due Diligence Period
04:42 AM | September 29, 2009 | Deepti Ramesh
Lonza says pharmaceutical contract manufacturing and development services company Patheon (Toronto), and Lonza have agreed to extend the exclusivity and due diligence period until October 15, 2009 to...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.